MedTrace Logo

Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages

NCT05445570 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3002

Last updated 2024-04-23

No results posted yet for this study

Summary

The NICE study is a prospective, multi-site study to train and validate a blood-based, glycoproteomic test for the early detection of advanced adenoma and colorectal cancer by collecting blood samples and associated relevant clinical information from average-risk participants who undergo routine screening colonoscopy as well as participants undergoing colonoscopy for surveillance or diagnostic indications

Conditions

Interventions

DIAGNOSTIC_TEST

Non-Interventional

This is an observational, non interventional study

Sponsors & Collaborators

  • Venn Biosciences Corporation

    lead INDUSTRY

Principal Investigators

  • Daniel Hommes, MD · InterVenn Biosciences

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-13
Primary Completion
2024-03-19
Completion
2024-03-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05445570 on ClinicalTrials.gov